Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.

NCT07072143 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Padova as lead sponsor.

NCT NCT07072143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
Lead sponsor
Azienda Ospedaliera di Padova
Phase
Observational
Overall status
Recruiting
Start date
January 25, 2025
Completion date
June 6, 2049
Enrollment
6,250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenocortical tumor, appendiceal cancers, esthesioneuroblastoma, olfactory, gastrointestinal stromal tumor (gist), melanoma and other malignant neoplasms of skin, mesothelioma, nasopharyngeal carcinoma (npc), nut carcinoma, pancreatic tumors, paraganglioma/ phaeochromocytoma, pleuropulmonary blastoma, salivary gland tumors, thymic tumors, thyroid carcinoma